 |
||
|
||
|
Topics
to be Discussed
|
|
|
FRIDAY, June 24 | |
|
SATURDAY, June 25 | |
|
SUNDAY, June 26 | |
|
MONDAY, June 27 | |
|
||
|
||
|
Topics
to be Discussed
|
|
|
FRIDAY, June 24 | |
|
SATURDAY, June 25 | |
|
SUNDAY, June 26 | |
|
MONDAY, June 27 | |
 |
 |
 |
 |
|
Topics
to be Discussed
|
|
1
|
New Developments in the Pathobiology of Prostate Disease | J. Schalken (NL). |
|
2
|
Advances in Biomarkers for Prostate Disease | R. Getzenberg (USA) |
|
3
|
Epidemiology and Natural History of Prostate Disease | M. Barry (USA) |
|
4
|
New Development in Imaging of the Prostate and Metastatic Sites | M. Resnick (USA) |
|
5
|
LUTS: Etiology and Patient Assessment |
P. Abrams (UK) |
|
6
|
New Medical Developments in the Management of LUTS in Adult Men | C. Chapple (UK) |
|
7
|
New Minimally-Invasive and Surgical Developments in the management of BPO | J. de la Rosette (NL) |
|
8
|
Prevention of BPH Outcomes and Clinical Progression | C. Roehrborn (USA) |
|
9
|
New Therapeutic Targets in BPH and LUTS (Research Priorities) | K-E. Andersson (E) |
|
10
|
New Developments in Screening and early Detection for Prostate Cancer | F. Schroeder (NL) |
| 11 | Prostate Cancer Chemoprevention | P. Gan (USA) |
| 12 | New Developments in the Treatment of Localized Prostate Cancer | F. Schroeder (NL) |
| 13 | New Therapeutic Targets and Treatments for Metastatic Prostate Cancer | W. Nelson (USA) |
| 14 | Androgen Replacement Therapy in Men at Risk for Prostate Disease | C.L Schulman (Belgium) |
| 15 | Prostatitis and Chronic Pelvic Pain | T. Schaeffer (USA) |
| 16 | Patient’s Perspectives in Prostate Diseases | T. Hudson (E) |
| History of Prostatic Diseases | D. Schultheiss-R. Waldbaum |
|
Chairpersons
|
|
Special
Keynote Address: The Cost of Prostate Disease on Society
|
|
Over
150 Experts in 16 Various Committees will discuss the following Topics
|